Title : Expanded polyglutamine-binding peptoid as a novel therapeutic agent for treatment of Huntington's disease.

Pub. Date : 2011 Sep 23

PMID : 21944750






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Polyglutamine(polyQ)-expanded proteins are potential therapeutic targets for the treatment of polyQ expansion disorders such as Huntington"s disease (HD) and spinocerebellar ataxia type 3 (SCA3). polyglutamine ataxin 3 Mus musculus
2 Polyglutamine(polyQ)-expanded proteins are potential therapeutic targets for the treatment of polyQ expansion disorders such as Huntington"s disease (HD) and spinocerebellar ataxia type 3 (SCA3). polyglutamine ataxin 3 Mus musculus
3 Polyglutamine(polyQ)-expanded proteins are potential therapeutic targets for the treatment of polyQ expansion disorders such as Huntington"s disease (HD) and spinocerebellar ataxia type 3 (SCA3). polyglutamine ataxin 3 Mus musculus